SB-611812

N/A

Report date: 2025/04/24 16:17:06
NME

Base Information

Drug NameSB-611812
Drug Alias Nameurotensin II receptor antagonist (GSK)SB-611812
ClassificationSmall molecules
Mechanisms of ActionUrotensin II receptor modulators
TargetsUrotensin II receptor
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A